通过免疫性细胞死亡基因分析对结直肠癌的预后和治疗见解

相关实验视频

Updated: Jun 22, 2025

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

Jinglu Yu¹, Yabin Gong², Zhenye Xu³

¹PuDong Traditional Chinese Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, Shanghai, Pudong, China.

|June 28, 2024

概括

这项研究引入了一种新的免疫细胞死亡 (ICD) 评分,以预测结直肠癌患者的结果和免疫治疗反应. 较高的ICD分数表明对癌症治疗的反应更好.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

免疫性细胞死亡 (ICD) 在瘤学中至关重要,但其在结直肠癌中的作用尚未完全理解.
了解ICD的影响可以改善结直肠癌的治疗策略.

研究的目的:

调查ICD在结直肠癌中的作用.
开发一种新的ICD量化系统,用于预测患者的治疗结果和免疫治疗的有效性.
根据ICD特征识别结直肠癌中的分子亚型.

主要方法:

利用单细胞测序在瘤免疫微环境 (TIME) 中创建一个ICD得分.
分析了来自TCGA和GEO数据集的1,184名结直肠腺癌患者的免疫细胞死亡相关基因 (ICDRGs).
采用主要组件分析 (PCA) 来建立ICD评分,并在三个独立队列中验证了该模型.

主要成果:

根据ICD得分,在结直肠腺癌中确定了两种不同的分子亚型.
开发的ICD得分准确地预测了免疫治疗的成功.
具有高ICD分数的患者表现出"热"的免疫表型和更好的免疫治疗反应.
关键基因 (AKAP12,CALB2,CYR61,MEIS2) 与瘤扩散,入侵和PD-L1表达的增加有关.

结论:

新型的ICD评分作为患者预后和结直肠癌免疫治疗反应的可靠预测指标.
针对ICD是一个有前途的战略,用于推进结直肠癌的抗瘤疗法.
这些发现有助于更深入地了解结直肠癌中瘤免疫微环境.

关键词:

结肠直肠癌是什么意思进行全面的分析分析.免疫原性细胞死亡免疫治疗是一种免疫疗法.

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

Published on: February 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.